SC 13G Filing

Company

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Filed

June 3, 2021

Accession Number

0001214659-21-006260

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →